TIL Therapy for Patients With Advanced Solid Tumors
NCT06107894
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Breast Cancer
Advanced Lung Cancer
Interventions
BIOLOGICAL:
Tumor-infiltrating lymphocytes
DRUG:
IL-2
Sponsor
NeogenTC